Furosemide Injection, Solution
Product Images NDC 0409-6102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 0409-6102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Novaplus Logo (Furosemide 02)
Principal Display Panel (2 mL Vial Label)
Principal Display Panel (2 mL Vial Tray)
This text appears to be a description of a medication package containing single-dose vials of 20 mg/2 mL solution for intravenous or intramuscular use. It mentions discarding unused portions, and includes a barcode with a GS1-128 format. Additionally, there are references to specific product numbers and dosing instructions for healthcare professionals.*
Principal Display Panel (4 mL Vial Label)
Description: A pharmaceutical product in the form of a 4 mL single-dose vial with 40mg/4 mL (10 mg/mL) concentration for intravenous or intramuscular use. The product is distributed by Hospira, Inc. from Lake Forest, IL, USA, under the Novaplus label. The unique FPO - GS1 Databar Stacked - 7.5 Mil barcode (01)00304096102366 is used for tracking and identification purposes. This medication is indicated for prescription use only and has the NDC 0409-6102-36 number for identification. It is essential not to use the product if the solution is discolored or contains particles.*
Principal Display Panel (4 mL Vial Tray)
Principal Display Panel (10 mL Vial Label)
Description: The text provides information about a Furosemide Injection packaged in a 10 mL single-dose vial for intravenous or intramuscular use. The product is identified by the Rxonly NDC number 0409-6102-3. Each mL of the injection contains 10 mg of Furosemide and 7.5 mg of Sodium Chloride for isotonicity. It is highlighted not to use if the solution is discolored or contains particulates. The product is distributed by Hospira, Inc. based in Lake Forest, IL 60045, USA.*
Principal Display Panel (10 mL Vial Tray)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.